Key highlights of the document:
- BPPI has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality since January 2018.
- While 17 out of the 18 companies are private, one is a public sector unit (PSU), the Indian Drugs and Pharmaceuticals Limited (IDPL).
- Of these, seven companies have been blacklisted for two years i.e. they are barred from supplying generic drugs to Janaushadhi scheme.
